Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Genetic and molecular mechanisms of chemical atherogenesis.

Ramos KS, Partridge CR, Teneng I.

Mutat Res. 2007 Aug 1;621(1-2):18-30. Epub 2007 Feb 28. Review.

PMID:
17433375
2.
3.

Oxidative stress, AGE, and atherosclerosis.

Schleicher E, Friess U.

Kidney Int Suppl. 2007 Aug;(106):S17-26. Review.

PMID:
17653206
4.

Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.

Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Praticò D, Harrison DG, Hsueh WA.

Circ Res. 2009 Mar 27;104(6):e42-54. doi: 10.1161/CIRCRESAHA.108.188771. Epub 2009 Mar 5.

5.

The impact of nitric oxide in cardiovascular medicine: untapped potential utility.

Pepine CJ.

Am J Med. 2009 May;122(5 Suppl):S10-5. doi: 10.1016/j.amjmed.2009.03.003. Review.

PMID:
19393821
6.

NAD(P)H oxidase and endothelial dysfunction.

Muller G, Morawietz H.

Horm Metab Res. 2009 Feb;41(2):152-8. doi: 10.1055/s-0028-1086023. Epub 2008 Sep 24. Review.

PMID:
18816427
7.

Oxidative stress, endothelial dysfunction and atherosclerosis.

Victor VM, Rocha M, Solá E, Bañuls C, Garcia-Malpartida K, Hernández-Mijares A.

Curr Pharm Des. 2009;15(26):2988-3002. Review.

PMID:
19754375
8.

Does reversal of oxidative stress and inflammation provide vascular protection?

Koh KK, Oh PC, Quon MJ.

Cardiovasc Res. 2009 Mar 1;81(4):649-59. doi: 10.1093/cvr/cvn354. Epub 2008 Dec 20. Review.

PMID:
19098298
9.

Differential vascular functions of Nox family NADPH oxidases.

Brandes RP, Schröder K.

Curr Opin Lipidol. 2008 Oct;19(5):513-8. doi: 10.1097/MOL.0b013e32830c91e3. Review.

PMID:
18769233
10.
11.

Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.

Selemidis S.

Clin Exp Pharmacol Physiol. 2008 Nov;35(11):1395-401. doi: 10.1111/j.1440-1681.2008.05055.x. Review.

PMID:
18954334
12.

MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis.

Hulsmans M, De Keyzer D, Holvoet P.

FASEB J. 2011 Aug;25(8):2515-27. doi: 10.1096/fj.11-181149. Epub 2011 Apr 20. Review.

PMID:
21507901
13.

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.

Förstermann U.

Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):338-49. doi: 10.1038/ncpcardio1211. Epub 2008 May 6. Review.

PMID:
18461048
14.

Targeting redox signaling in the vascular wall: from basic science to clinical practice.

Antoniades C, Antonopoulos AS, Bendall JK, Channon KM.

Curr Pharm Des. 2009;15(3):329-42. Review.

PMID:
19149622
15.

Molecular genetics of atherosclerosis.

Roy H, Bhardwaj S, Yla-Herttuala S.

Hum Genet. 2009 Jun;125(5-6):467-91. doi: 10.1007/s00439-009-0654-5. Epub 2009 Mar 20. Review.

PMID:
19301036
16.

Oxidative stress, endothelial dysfunction and cerebrovascular disease.

Zalba G, Fortuño A, San José G, Moreno MU, Beloqui O, Díez J.

Cerebrovasc Dis. 2007;24 Suppl 1:24-9. Epub 2007 Nov 1. Review.

PMID:
17971636
17.

Thiazide diuretics, endothelial function, and vascular oxidative stress.

Zhou MS, Schulman IH, Jaimes EA, Raij L.

J Hypertens. 2008 Mar;26(3):494-500. doi: 10.1097/HJH.0b013e3282f3e39d.

PMID:
18300860
18.
19.

LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.

Morawietz H.

Circ Res. 2007 Jun 8;100(11):1534-6. No abstract available.

20.

Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2.

Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone MA Jr.

Circ Res. 2007 Sep 28;101(7):723-33. Epub 2007 Aug 2.

Supplemental Content

Support Center